Prep

Acronym for HIV pre-exposure prophylaxis. PrEP is a therapeutic procedure with which HIV-negative people who are exposed to a possible risk can protect themselves against HIV infection by taking antiviral medication(emtricitabine + tenovir) as a preventive measure. 2 published studies (PROUD, IPERGAY) have demonstrated the high efficacy of this medication.

Since September 2019, PrEP is a benefit of the statutory health insurance for people with "substantial" HIV risk.

1. McCormack S et al (2016) Pre-exposure prophylaxis prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 387:53-60.
2. Sagaon-Teyssier L et al (2016) Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care 28 Suppl 1:48-55.
3. https://www.aerzteblatt.de/nachrichten/132834/-Fazit-nach-mehr-als-zwei-Jahren-HIV-Praeexpositionsprophylaxe-als-Kassenleistung